Company / Return on Equity (ROE)
Bioventus Inc. Return on Equity (ROE) History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
12.3%
FY2025
5-year range
-48.8% / 12.3%
FY2021-FY2025
Trend
+150.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Equity (ROE) has fluctuated over the past 5 years, ranging from -48.8% in FY2022 to 12.3% in FY2025.
Based on SEC 10-K filings.
12.3% in FY2025 with a 3-year CAGR of +61.1%.
Improved from 11.2% to 12.3% over the past 2 years.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +61.1pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on equity (roe) increased 150.6% year-over-year.
- Lowest return on equity (roe) in the period was in FY2022.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 12.3% | +150.6% |
| FY2024 | -24.4% | -318.8% |
| FY2023 | 11.2% | +122.9% |
| FY2022 | -48.8% | -3375.2% |
| FY2021 | 1.5% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026